CKPT insider transaction filings
Checkpoint Therapeutics, Inc. — 16 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2025-06-03. Screen CKPT transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2025-06-03 | 4 | Fortress Biotech, Inc. — 10% owner | Sale (S): 100,000 @ $1.29 · Disposition to issuer (D): 6,122,249 @ $4.10 · Disposition to issuer (D): 700,000 (derivative) @ $0 | EDGAR |
| 2025-05-30 | 4 | ROSENWALD LINDSAY A MD — Director | Grant/award (A): 12,195 @ $0 · Grant/award (A): 50,000 @ $1.29 · Code (U): 207,007 | EDGAR |
| 2025-05-30 | 4 | GRAY WILLIAM GARRETT — Chief Financial Officer | Code (U): 1,446,322 | EDGAR |
| 2025-05-30 | 4 | Amit Sharma — Director | Grant/award (A): 12,195 @ $0 · Code (U): 94,246 | EDGAR |
| 2025-05-30 | 4 | Oliviero James F III — CEO, President and Director, Director | Code (U): 3,759,929 | EDGAR |
| 2025-05-30 | 4 | SALZMAN BARRY M — Director | Grant/award (A): 12,195 @ $0 · Code (U): 147,007 | EDGAR |
| 2025-05-30 | 4 | Bechon Christian — Director | Grant/award (A): 12,195 @ $0 · Code (U): 141,718 | EDGAR |
| 2025-05-30 | 4 | Herskowitz Neil — Director | Grant/award (A): 12,195 @ $0 · Code (U): 147,007 | EDGAR |
| 2025-05-30 | 4 | WEISS MICHAEL S — Director | Grant/award (A): 12,195 @ $0 · Grant/award (A): 50,000 @ $1.29 · Code (U): 187,007 | EDGAR |
| 2025-04-03 | 4 | GRAY WILLIAM GARRETT — Chief Financial Officer | Sale (S): 12,322 @ $4.05 | EDGAR |
| 2025-04-03 | 4 | Oliviero James F III — CEO, President and Director, Director | Sale (S): 15,090 @ $4.04 | EDGAR |
| 2025-02-27 | 4 | Fortress Biotech, Inc. — 10% owner | Grant/award (A): 18,500 @ $0 | EDGAR |
| 2025-02-11 | 4 | Oliviero James F III — CEO, President and Director, Director | Sale (S): 9,233 @ $3.41 · Sale (S): 10,331 @ $3.15 | EDGAR |
| 2025-02-07 | 4 | GRAY WILLIAM GARRETT — Chief Financial Officer | Sale (S): 74,110 @ $3.67 | EDGAR |
| 2025-01-31 | 4 | GRAY WILLIAM GARRETT — Chief Financial Officer | Grant/award (A): 500,000 @ $0 | EDGAR |
| 2025-01-31 | 4 | Oliviero James F III — CEO, President and Director, Director | Grant/award (A): 1,500,000 @ $0 | EDGAR |
Recent 8-K events — Checkpoint Therapeutics, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2025-05-30 | 8-K | 1.02 — Termination of a Material Definitive Agreement 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-05-29 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2025-05-22 | 8-K | 8.01 — Other Events | EDGAR |
| 2025-05-13 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-04-15 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-03-28 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-03-10 | 8-K | 1.01 — Entry into a Material Definitive Agreement 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=CKPT returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →